FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
KraneShares MSCI All China Health Care Index ETF ETF AnalysisComprehensive ETF analysis for KraneShares MSCI All China Health Care Index ETF (KURE) including NAV, expense ratio, sector breakdown, and holdings data.ETF AnalysisKURE
KURE
KraneShares MSCI All China Health Care Index ETF
KURE
  1. Home
  2. Screener
  3. KraneShares MSCI All China Health Care Index ETFKUREETF
KraneShares MSCI All China Health Care Index ETF Logo

KraneShares MSCI All China Health Care Index ETF

ETF
🇺🇸KURE•AMEX•Equity

Your view on KURE

KraneShares MSCI All China Health Care Index ETF Logo

KraneShares MSCI All China Health Care Index ETF

ETFKraneShares
🇺🇸KURE•AMEX•Equity
AUM (USD)$104.71M
Expense Ratio0.79%
Holdings53

Sentiment

AUM (USD)

$104.71M

Expense Ratio

0.79%

Holdings

53

Sentiment

KURE
KraneShares MSCI All China Health Care Index ETF
KURE

Overview for KraneShares MSCI All China Health Care Index ETF

Fund Type
ETF
Fund Issuer
KraneShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
January 31, 2018
Domicile
US
Website
kraneshares.com/KURE
Fund Type
ETF
Fund Issuer
KraneShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
January 31, 2018
Domicile
US
Website
kraneshares.com/KURE
Fund Type
ETF
Fund Issuer
KraneShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
January 31, 2018
Domicile
US
Website
kraneshares.com/KURE

About this fund

KURE seeks to measure the performance of MSCI China All Shares Healthcare 10/40 Index. The Index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the healthcare sector. The securities in …

KURE Stock Price

Key Facts

Equity

Expense Ratio

0.79%

AUM

$104.71M

Fund Details

NAV$17.75 USD
Holdings53
Average Volume50.9K
Inception DateJanuary 31, 2018
Asset ClassEquity
Fund IssuerKraneShares
DomicileUS
ISINUS5007678353
CUSIP500767835
NAV CurrencyUSD

Expense Ratio

0.79%

Assets Under Management

$104.71M

NAV

$17.75 USD

Holdings

53

Average Volume

50.9K

Inception Date

January 31, 2018

Asset Class

Equity

Fund Issuer

KraneShares

Domicile

US

ISIN

US5007678353

CUSIP

500767835

NAV Currency

USD

Expense Ratio

0.79%

Assets Under Management

$104.71M

NAV

$17.75 USD

Holdings

53

Average Volume

50.9K

Inception Date

January 31, 2018

Asset Class

Equity

Fund Issuer

KraneShares

Domicile

US

ISIN

US5007678353

CUSIP

500767835

NAV Currency

USD

Data last updated: Sep 14, 2026, 07:10 AM

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

News

Latest Market News

What is KURE?

KraneShares MSCI All China Health Care Index ETF (KURE) is a Equity fund from KraneShares, listed since 2018, with $104.7M in assets under management, a 0.79% expense ratio, a NAV of $17.75 USD.

What's in KURE? Top 10 holdings

HoldingWeight
Innovent Biologics INC 1801.HK8.55%
Beone Medicines LTD-H 6160.HK8.45%
Wuxi Biologics Cayman INC 2269.HK7.97%
Wuxi Apptec Co LTD-A 603259.SS5.90%
Akeso INC 9926.HK4.67%
Jiangsu Hengrui Pharmaceut-A 600276.SS4.54%
Shenzhen Mindray Bio-Medic-A 300760.SZ4.45%
Cspc Pharmaceutical Group Lt 1093.HK3.78%
Sino Biopharmaceutical 1177.HK3.72%
Genscript Biotech CORP 1548.HK3.58%

KURE sector breakdown

  • Healthcare 99.12%
  • Consumer Defensive 0.88%

Comparable funds

  • ALTLPacer Lunt Large Cap Alternator ETF
  • AMIDArgent Mid Cap ETF
  • FEBWAllianzIM U.S. Equity Buffer20 Feb ETF
  • GSEUGoldman Sachs ActiveBeta Europe Equity ETF
  • INDSPacer Industrial Real Estate ETF
  • IVVBiShares Large Cap Deep Quarterly Laddered ETF
  • PHEQParametric Hedged Equity ETF
  • RSPRInvesco S&P 500 Equal Weight Real Estate ETF

More KraneShares ETFs

  • KARSKraneShares Electric Vehicles & Future Mobility Index ETF
  • KBAKraneShares Bosera MSCI China A 50 Connect Index ETF**
  • KBABKraneShares 2X Long BABA Daily ETF​
  • KBDUKraneShares 2X Long BIDU Daily ETF​
  • KBUFKraneShares 90% KWEB Defined Outcome January 2027 ETF
  • KCAIKraneShares China Alpha Index ETF
  • KCCAKraneShares California Carbon Allowance Strategy ETF
  • KCSHKraneShares Sustainable Ultra Short Duration Index ETF​
  • KEMQKraneShares Emerging Markets Consumer Technology ETF
  • KEMXKraneShares MSCI Emerging Markets ex China Index ETF
  • KGRNKraneShares MSCI China Clean Technology Index ETF*
  • KHYBKraneShares Asia Pacific High Income USD Bond ETF*